Blepharitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Blepharitis defines the inflammation
of the eyelid margin and is one of the most commonly found conditions in
ophthalmic practice being a frequent cause of ocular irritation and discomfort.
Blepharitis can be classified as anterior when the inflammatory process affects
the base of the eyelashes, ciliary follicles, and the palpebral skin, or
posterior when there is dysfunction of the Meibomian glands located on the
posterior eyelid margin. Anterior blepharitis is divided into staphylococcal
and seborrheic. The first has hard crushes at the base of the eyelashes and is
the result of an abnormal cellular response to the cell wall components of
Staphylococcus aureus (S.aureus). The second is frequently associated with
generalized seborrheic dermatitis and has soft, greasy crusts that stick to the
eyelashes. Blepharitis has a multifactorial pathogenic mechanism, and its
etiology is not clearly known. Evidence indicates a relation with infectious,
allergic, systemic, and environmental components. Therefore, treatment regimens
can often fail.
- The prevalence of Blepharitis may vary from 27.0% to 35.0%
adult population. Females accounted for 60% of cases and males for 40%.
Regarding the severity of the disease, more than half were diagnosed with
mild blepharitis 55% to 57.8% and 40% to 42.6% cases diagnosed with
moderate, and 1.6% to 3.5% as severe.
Thelansis’s “Blepharitis Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Blepharitis
treatment modalities options for eight major markets (USA, Germany, France,
Italy, Spain, UK, Japan, and China).
KOLs insights
of Blepharitis across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Blepharitis Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment